1. The amount of 1-dimethylaminonaphthalene-5-sulphonamide formed during the reaction of an amino acid with 1-dimethylaminonaphthalene-5-sulphonyl chloride depends on the structure of the amino acid and on the conditions used. 2. The reaction probably involves attack of a further molecule of 1-dimethylaminonaphthalene-5-sulphonyl chloride on the 1-dimethylaminonaphthalene-5-sulphonyl-amino acid and also gives the aldehyde (or ketone) with one carbon atom less than the parent amino acid.

Journal Article↗

PubMedDate not supplied

International perspectives on newborn screening.

The development of electrospray tandem mass spectrometry (MS-MS) has greatly increased the number of diseases that can be detected by newborn blood-spot screening. Different countries are introducing the technology at different rates and for different disease panels. Current policies in the United Kingdom, Germany and the United States are taken as examples. In the United Kingdom, many laboratories are using MS-MS for routine screening for phenylketonuria but, except for those participating in a two-year pilot study of screening for medium-chain acyl-CoA dehydrogenase deficiency, are forbidden use MS-MS to screen for other disorders. In Germany there has been considerable experience of MS-MS screening for a wide range of diseases, but recently the Federal Ministry for Health and Social Security prescribed a much more restricted disease panel, with the instruction that any other diagnostic results are to be suppressed and not reported. By contrast, a recent report from the American College of Medical Genetics, still being debated, recommends screening procedures that will detect an extremely broad range of disorders, including some that are very rare or of unproven clinical significance. The lack of even broad concordance at the level of national policy is extremely disturbing. Though all discussion is nominally founded on the ten principles laid down by Wilson and Jungner in 1968, there seems no generally accepted way of using these principles, or derived criteria, as objective decision tools. Alternative, less categorical, approaches are needed: the disorders concerned are not homogeneous entities and there may be advantages to screening other than reducing morbidity or mortality.

Germany↗

PubMedDate not supplied

Screening siblings for inborn errors of fatty acid metabolism in families with a history of sudden infant death.

Explore the source record for details and available documents.

Fatty Acids↗

PubMedDate not supplied

[Pathological and biochemical studies on a neonatal case of argininosuccinic aciduria (author's transl)].

A newborn infant affected by argininosuccinic aciduria was treated with a hypoproteinaemic diet and survived up to the age of three months. Post mortem biochemical studies have confirmed the absence of argininosuccinase activity in kidney, liver and brain and a marked storage of argininosuccinic acid in the brain. The histological study of the central nervous system shows no Alzheimer type II cells; there is neither demyelination nor spongiosis. Such results are totally different from those recorded in untreated cases; they represent very likely the effects of the diet which has controlled the hyperammoniaemia and prevented a deficiency of arginine.

Amino Acid Metabolism, Inborn Errors↗